Personalized mRNA vaccine for pancreatic cancer, Vast Space's space station, Yellowstone tremor music and fish acoustics

Episode snapshot

The Naked Scientists explore breakthroughs in medicine and space science this week. The show highlights a personalised mRNA vaccine that targets pancreatic cancer after surgery, a collaboration between Vast Space and SpaceX to launch a small commercial space station, turning Yellowstone tremor data into musical compositions, and the world of fish acoustics used for species identification and habitat management. It also touches on Japans Covid policy shift and how public health policy reacts to changing risks.

• First insight: 50 percent of treated patients showed no cancer recurrence in follow up 18 months; personalised vaccine built from patient tumor mutations
• Second: fast delivery platform for multi target vaccines using mRNA
• Third: turning seismic activity at Yellowstone into music as a data interpretation tool
• Fourth: fish acoustics inform species ID and essential fish habitat planning

Overview

The Naked Scientists deliver a broad look at science breakthroughs across medicine, space and ecology in this episode. The program begins with a detailed discussion of a pioneering personalised messenger RNAmRNA vaccine for pancreatic cancer, then shifts to aerospace entrepreneurship, followed by two pieces on science communication through sound. The content is presented through interviews and expert commentary, offering listeners a window into how cutting edge research translates into potential real world impact.

Personalised mRNA vaccines for pancreatic cancer

The programme centres on a study led by Vinod Balachandran, a surgical oncologist at Memorial Sloan Kettering Cancer Center, who reports a personalised mRNA vaccine regimen for pancreatic cancer. The approach uses the genetic profile of each patient’s tumor to identify mutations that generate novel cancer specific proteins. These mutated protein sequences become targets for a personalised vaccine platform based on mRNA delivery. The clinical trial started in December 2019, with sixteen patients treated, including post operative vaccine administration after surgical tumor removal. The team shipped tumor samples to Germany within 72 hours for genetic analysis and vaccine production before returning them to New York for patient administration. The results show that half of treated patients mounted a measurable immune response and experienced no cancer recurrence during an 18 month median follow up. In contrast, patients who did not mount an immune response tended to recur within about 13 months. While this is a phase 1 study with a small number of participants, the outcomes are encouraging enough to warrant broader testing. The discussion illuminates the logistical and scientific challenges inherent in personalised cancer vaccines such as targeted selection of mutations and rapid vaccine manufacturing. The interview also addresses the concept that the immune system can, in some patients, keep cancer at bay long term, and that vaccines could potentially induce those favorable immune conditions in more patients. Balachandran’s findings have been published in Nature, underscoring the potential significance of a patient specific, mRNA based vaccine approach to cancer therapy and the role of tumor specific mutations as immune targets.

Vast Space and Haven One space station

The episode moves to space where Vast Space, a startup partnering with SpaceX, announces plans to launch the first commercial space station by as early as 2025. The station, Haven One, will be a compact, satellite sized module, designed to host simple experiments and eventually expand module by module. Initially uncrewed tests will precede crewed missions using a Dragon capsule. The venue is described as a platform for private science and commercial research, capable of supporting a crew of four on each mission. The conversation highlights that this is a realistic, not a grand ISS scale project, and notes the strategic advantage of leveraging SpaceX infrastructure, Dragon life support systems, and the established approach to crewed missions. There is recognition that the ISS is aging and facing potential end of operations around 2030, creating a potential market window for smaller specialized stations focused on materials science, biology, technology development and even space tourism. The feature also notes the involvement of a founder described as a cryptocurrency billionaire who has invested hundreds of millions of dollars, illustrating the growing role of private finance in space ventures. The broader context suggests a potential early ecosystem for a fleet of small space stations with various specializations, filling a gap as international collaboration and long duration missions evolve in the space industry.

Yellowstone tremor to music

In another segment, Domenico Vicinanza, a senior lecturer at Anglia Ruskin University, discusses turning Yellowstone National Park real time seismic data into music. The concept relies on sonification, translating the oscillations of a seismometer needle into musical melodies. Large seismic events create dramatic musical intervals and high and low notes that reflect the actual waveforms. The aim is to provide a visceral, audible representation of geophysical processes and to demonstrate how data can be experienced beyond traditional visual representations. Vicinanza has previously experimented with translating energy levels at the Large Hadron Collider into sound as well as seismic activity. The discussion also touches on how this approach can provide an intuitive sense of calm vs drama and offers a unique accessibility angle for understanding difficult science topics for diverse audiences.

Fish acoustics and essential habitat management

Will Tingle reports on research into fish sound production and what it reveals about behavior and habitat. The International Quiet Ocean Experiment and its Global Library of Underwater Biological Sounds catalogued fish sounds, many produced by the swim bladder via specialized muscles. The depth and frequency of sounds are related to fish size and mating status, providing a potential acoustic fingerprint for species identification especially in murky waters. The interview explains that fish harness a variety of sounds for spawning, territory, distress, and possible feeding communication. Changes in environment and anthropogenic noise alter patterns of calling and can reduce mating success by shrinking the acoustic space available for communication. The discussion highlights the value of marine acoustics for fisheries management, enabling you to locate critical spawning periods and essential fish habitats and to implement time and space based closures to protect vulnerable populations while supporting sustainable fisheries.

Covid in Japan and public health policy

The program closes with a discussion on Japan stepping back from strict COVID-19 restrictions after the World Health Organization characterized the emergency as no longer a crisis. Japanese authorities will treat COVID-19 similarly to seasonal flu in terms of restrictions. Sir David Warren, former UK ambassador to Japan, comments on the cautious cultural approach to risk, including risk averse behaviors such as mask wearing and temperature checks that have persisted due to experience with SARS. The interview suggests that policy shifts balance the need to reopen to tourism and business with the ongoing need to be prepared for future health threats. The conversation emphasizes Japan's unique risk environment shaped by past public health experiences and geopolitics, and notes that the WHO declaration helps justify economic reopening while maintaining vigilance against potential future outbreaks.

Conclusion

Across medicine, space, acoustics and public health the episode demonstrates how collaborative science can push forward in multiple directions. The Naked Scientists present a mosaic of ideas that illuminate how cutting edge research translates into potential medical breakthroughs, new business opportunities, and creative ways to engage the public with science.